Hoylecohen LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 202.7% during the fourth quarter, Holdings Channel reports. The firm owned 23,133 shares of the medical equipment provider’s stock after buying an additional 15,490 shares during the quarter. Hoylecohen LLC’s holdings in Intuitive Surgical were worth $8,312,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Edgewood Management LLC lifted its stake in Intuitive Surgical by 200.2% in the 3rd quarter. Edgewood Management LLC now owns 8,528,553 shares of the medical equipment provider’s stock valued at $2,826,220,000 after purchasing an additional 5,687,456 shares during the last quarter. Geode Capital Management LLC grew its holdings in Intuitive Surgical by 207.0% in the fourth quarter. Geode Capital Management LLC now owns 6,385,862 shares of the medical equipment provider’s stock worth $2,288,520,000 after purchasing an additional 4,305,989 shares during the period. Fisher Asset Management LLC grew its holdings in Intuitive Surgical by 215.3% in the fourth quarter. Fisher Asset Management LLC now owns 4,313,145 shares of the medical equipment provider’s stock worth $1,549,713,000 after purchasing an additional 2,945,104 shares during the period. Baillie Gifford & Co. grew its holdings in shares of Intuitive Surgical by 191.5% during the fourth quarter. Baillie Gifford & Co. now owns 4,401,406 shares of the medical equipment provider’s stock valued at $1,581,425,000 after buying an additional 2,891,713 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in Intuitive Surgical by 200.2% during the fourth quarter. Northern Trust Corp now owns 3,911,386 shares of the medical equipment provider’s stock worth $1,405,362,000 after purchasing an additional 2,608,267 shares during the last quarter. Institutional investors and hedge funds own 83.69% of the company’s stock.
Intuitive Surgical stock traded up $0.93 during mid-day trading on Friday, hitting $219.07. The company had a trading volume of 1,818,012 shares, compared to its average volume of 2,720,486. Intuitive Surgical, Inc. has a 12-month low of $206.60 and a 12-month high of $369.69. The company’s fifty day moving average is $263.77 and its 200-day moving average is $299.19. The company has a market capitalization of $78.64 billion, a price-to-earnings ratio of 48.72, a P/E/G ratio of 4.98 and a beta of 1.26.
In other news, EVP Myriam Curet sold 6,000 shares of the stock in a transaction on Tuesday, April 26th. The stock was sold at an average price of $252.51, for a total transaction of $1,515,060.00. Following the completion of the transaction, the executive vice president now directly owns 361 shares in the company, valued at approximately $91,156.11. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.90% of the stock is owned by company insiders.
Several analysts have recently issued reports on the stock. Morgan Stanley lowered their price target on shares of Intuitive Surgical from $325.00 to $300.00 and set an “equal weight” rating on the stock in a research report on Monday, April 25th. Piper Sandler boosted their price target on shares of Intuitive Surgical from $310.00 to $316.00 and gave the stock an “overweight” rating in a research note on Friday, April 22nd. Royal Bank of Canada started coverage on shares of Intuitive Surgical in a research note on Friday, March 25th. They issued an “outperform” rating and a $340.00 price objective for the company. Stifel Nicolaus cut their price objective on shares of Intuitive Surgical from $370.00 to $325.00 and set a “buy” rating for the company in a research note on Friday, January 21st. Finally, Wells Fargo & Company lowered their price target on shares of Intuitive Surgical from $350.00 to $339.00 and set an “overweight” rating for the company in a report on Friday, April 22nd. Eight investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $323.70.
About Intuitive Surgical (Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- MarketBeat: Week in Review 5/16 – 5/20
- 3 Retailers That Defied First Quarter Headwinds
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Will John Deere’s Earnings Help to Calm the Markets?
- Lowe’s Companies Has Not Bottomed
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.